Theralia AB is a pioneering biotech company dedicated to revolutionizing how nucleoside analogues are employed in diverse therapeutic landscapes.
Innovative Drug Delivery through TOUCAN: A New Horizon
TOUCAN, our groundbreaking drug delivery technology, paves the way for a new era of medical intervention. We are overcoming the limitations posed by conventional systemic and naked delivery approaches, often fraught with the specter of high toxicity and suboptimal treatment outcomes.
Our Mission: Safety, Efficacy, and Accessibility
At the heart of our mission lies a resolute commitment to refining the safety and efficacy of nucleoside analogues and other drugs. Our aim is to enhance the safety profile and efficacy of existing therapeutic drugs, making them accessible to a broader patient population and improving treatment outcomes.
Company Details
- Employees
- 3
- Address
- Linköping, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.theralia.com/
- HQ
- Linköping
Theralia Ab Questions
Theralia Ab's website is https://www.theralia.com/
Theralia Ab's LinkedIn profile is https://se.linkedin.com/company/theralia-ab
Theralia Ab has
3 employees.
View email and phone details for 3
employees at Theralia Ab.
Theralia Ab's industry is
Biotechnology Research
Theralia Ab's top competitors are
Digiclean Solutions Ab,
Paralos Bioscience,
Omnicin Therapeutics,
Dyno Robotics,
Brigid Bio,
Polar Light Technologies,
Microplate Dx Limited,
Stilfold — Greener By Every Fold,
Incredible,
Renasens.
Theralia Ab's categories are Biotechnology Research
